JP2007509852A5 - - Google Patents

Download PDF

Info

Publication number
JP2007509852A5
JP2007509852A5 JP2006536055A JP2006536055A JP2007509852A5 JP 2007509852 A5 JP2007509852 A5 JP 2007509852A5 JP 2006536055 A JP2006536055 A JP 2006536055A JP 2006536055 A JP2006536055 A JP 2006536055A JP 2007509852 A5 JP2007509852 A5 JP 2007509852A5
Authority
JP
Japan
Prior art keywords
ethyl
hydroxy
phenyl
alkyl
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006536055A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007509852A (ja
Filing date
Publication date
Priority claimed from GBGB0324886.1A external-priority patent/GB0324886D0/en
Application filed filed Critical
Publication of JP2007509852A publication Critical patent/JP2007509852A/ja
Publication of JP2007509852A5 publication Critical patent/JP2007509852A5/ja
Pending legal-status Critical Current

Links

JP2006536055A 2003-10-24 2004-10-21 フェネタノールアミン誘導体 Pending JP2007509852A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0324886.1A GB0324886D0 (en) 2003-10-24 2003-10-24 Medicinal compounds
PCT/EP2004/011963 WO2005044787A1 (en) 2003-10-24 2004-10-21 Phenetanolamine derivatives

Publications (2)

Publication Number Publication Date
JP2007509852A JP2007509852A (ja) 2007-04-19
JP2007509852A5 true JP2007509852A5 (OSRAM) 2007-10-11

Family

ID=29595788

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006536055A Pending JP2007509852A (ja) 2003-10-24 2004-10-21 フェネタノールアミン誘導体

Country Status (5)

Country Link
US (1) US20070135490A1 (OSRAM)
EP (1) EP1675821A1 (OSRAM)
JP (1) JP2007509852A (OSRAM)
GB (1) GB0324886D0 (OSRAM)
WO (1) WO2005044787A1 (OSRAM)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005009958A1 (en) 2003-07-17 2005-02-03 Plexxikon, Inc. Ppar active compounds
US7348338B2 (en) 2003-07-17 2008-03-25 Plexxikon, Inc. PPAR active compounds
GT200500281A (es) 2004-10-22 2006-04-24 Novartis Ag Compuestos organicos.
GB0424284D0 (en) 2004-11-02 2004-12-01 Novartis Ag Organic compounds
GB0426164D0 (en) 2004-11-29 2004-12-29 Novartis Ag Organic compounds
US7531568B2 (en) 2004-11-30 2009-05-12 Plexxikon, Inc. PPAR active compounds
EP2281813A1 (en) 2005-08-08 2011-02-09 Pulmagen Therapeutics (Synergy) Limited Bicyclo[2.2.1]hept-7-ylamine derivatives and their uses
GB0516313D0 (en) 2005-08-08 2005-09-14 Argenta Discovery Ltd Azole derivatives and their uses
TW200738658A (en) 2005-08-09 2007-10-16 Astrazeneca Ab Novel compounds
TW200800872A (en) * 2005-09-07 2008-01-01 Plexxikon Inc PPAR active compounds
JP5006330B2 (ja) 2005-10-21 2012-08-22 ノバルティス アーゲー Ｉｌ１３に対するヒト抗体および治療的使用
GB0601951D0 (en) 2006-01-31 2006-03-15 Novartis Ag Organic compounds
TW200745084A (en) * 2006-03-08 2007-12-16 Astrazeneca Ab Novel compounds
TW200745067A (en) 2006-03-14 2007-12-16 Astrazeneca Ab Novel compounds
HRP20120494T1 (hr) 2006-04-21 2012-08-31 Novartis Ag Derivati purina za uporabu kao agonista adenozin a2a receptora
TW200833670A (en) 2006-12-20 2008-08-16 Astrazeneca Ab Novel compounds 569
GB0702458D0 (en) 2007-02-08 2007-03-21 Astrazeneca Ab Salts 668
PE20090159A1 (es) 2007-03-08 2009-02-21 Plexxikon Inc COMPUESTOS DERIVADOS DE ACIDO INDOL-PROPIONICO COMO MODULADORES PPARs
WO2009087224A1 (en) 2008-01-11 2009-07-16 Novartis Ag Pyrimidines as kinase inhibitors
UY31905A (es) 2008-06-18 2010-01-29 Astrazeneca Ab Derivados de benzoxazinona, procesos de preparación, composiciones farmacéuticas conteniéndolos y aplicaciones.
US8236786B2 (en) 2008-08-07 2012-08-07 Pulmagen Therapeutics (Inflammation) Limited Respiratory disease treatment
PL2379507T3 (pl) 2008-12-30 2014-03-31 Pulmagen Therapeutics Inflammation Ltd Związki sulfonamidu do leczenia zaburzeń układu oddechowego
WO2010150014A1 (en) 2009-06-24 2010-12-29 Pulmagen Therapeutics (Inflammation) Limited 5r- 5 -deuterated glitazones for respiratory disease treatment
GB0918924D0 (en) 2009-10-28 2009-12-16 Vantia Ltd Azaindole derivatives
GB0918923D0 (en) 2009-10-28 2009-12-16 Vantia Ltd Aminothiazole derivatives
GB0918922D0 (en) 2009-10-28 2009-12-16 Vantia Ltd Aminopyridine derivatives
WO2011098746A1 (en) 2010-02-09 2011-08-18 Pulmagen Therapeutics (Inflammation) Limited Crystalline acid addition salts of ( 5r) -enanti0mer of pioglitazone
GB201002224D0 (en) 2010-02-10 2010-03-31 Argenta Therapeutics Ltd Respiratory disease treatment
GB201002243D0 (en) 2010-02-10 2010-03-31 Argenta Therapeutics Ltd Respiratory disease treatment
WO2012034095A1 (en) 2010-09-09 2012-03-15 Irm Llc Compounds and compositions as trk inhibitors
UY33597A (es) 2010-09-09 2012-04-30 Irm Llc Compuestos y composiciones como inhibidores de la trk
JP5959541B2 (ja) 2011-02-25 2016-08-02 ノバルティス アーゲー Ｔｒｋ阻害剤としてのピラゾロ［１，５−ａ］ピリジン
TWI767148B (zh) 2018-10-10 2022-06-11 美商弗瑪治療公司 抑制脂肪酸合成酶(fasn)
WO2023097697A1 (zh) * 2021-12-03 2023-06-08 广东莱佛士制药技术有限公司 一种合成(1r)-1-(2,2-二甲基-4h-1,3-苯并二噁英-6-基)噁唑啉-2-酮的方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR8007911A (pt) * 1979-12-06 1981-06-16 Glaxo Group Ltd Inalador aperfeicoado
ZA824902B (en) * 1981-07-11 1983-04-27 Beecham Group Plc Secondary amines
WO1984000956A1 (en) * 1982-08-27 1984-03-15 Beecham Group Plc Secondary arylethanolamines
US4778054A (en) * 1982-10-08 1988-10-18 Glaxo Group Limited Pack for administering medicaments to patients
ZW6584A1 (en) * 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
GB2178965B (en) * 1985-07-30 1988-08-03 Glaxo Group Ltd Devices for administering medicaments to patients
DE3884363T2 (de) * 1987-12-18 1994-01-20 Glaxo Group Ltd Ethanolaminderivate.
GB9004781D0 (en) * 1990-03-02 1990-04-25 Glaxo Group Ltd Device
SK279958B6 (sk) * 1992-04-02 1999-06-11 Smithkline Beecham Corporation Zlúčeniny s protialergickým a protizápalovým účink
US5998428A (en) * 1995-05-31 1999-12-07 Smithkline Beecham Corporation Compounds and methods for treating PDE IV-related diseases
US6514996B2 (en) * 1995-05-19 2003-02-04 Kyowa Hakko Kogyo Co., Ltd. Derivatives of benzofuran or benzodioxole
GB9700226D0 (en) * 1997-01-08 1997-02-26 Glaxo Group Ltd Inhalation device
US6632666B2 (en) * 2000-01-14 2003-10-14 Biolife Solutions, Inc. Normothermic, hypothermic and cryopreservation maintenance and storage of cells, tissues and organs in gel-based media
EP1497261B1 (en) * 2002-04-25 2007-12-19 Glaxo Group Limited Phenethanolamine derivatives
NZ539676A (en) * 2002-10-28 2006-10-27 Glaxo Group Ltd Phenethanolamine derivative for the treatment of respiratory diseases
GB0225540D0 (en) * 2002-11-01 2002-12-11 Glaxo Group Ltd Medicinal compounds
GB0303396D0 (en) * 2003-02-14 2003-03-19 Glaxo Group Ltd Medicinal compounds

Similar Documents

Publication Publication Date Title
JP2007509852A5 (OSRAM)
JP2005523920A5 (OSRAM)
RU2312854C2 (ru) Производные фенэтаноламина для лечения респираторных заболеваний
JP2007509103A5 (OSRAM)
JP2006506373A5 (OSRAM)
US8518980B2 (en) Treatment of Duchenne muscular dystrophy
TWI511728B (zh) 包含非典型抗精神病藥物及taar1激動劑之醫藥組合
US8039674B2 (en) Compound having S1P receptor binding potency and use thereof
RU2005111975A (ru) Производные фенэтаноламина для лечения респираторных заболеваний
JP6506322B2 (ja) 新規な抗不安薬化合物
JP2005519083A5 (OSRAM)
JP2006504766A5 (OSRAM)
JP2000504677A (ja) ５ｈｔ７レセプター・アンタゴニスト用のスルホンアミド誘導体
RU2004104625A (ru) Аналоги простагландинов в качестве агонистов рецептора ep4
JP2007514691A5 (OSRAM)
CN101420950B (zh) 杜兴肌营养不良的治疗
CA2618511A1 (en) Novel benzothiazolone derivatives
TWI794856B (zh) 製備具有經取代之苯基或吡啶基部分的ｓｅｒｄ三環化合物的方法
JP2008512438A (ja) 療法用ジフェニルエーテル系リガンド
JP2005532397A5 (OSRAM)
CN1202106A (zh) 选择性的β3肾上腺素能激动剂
US20110092468A1 (en) Pharmaceutical Calcimimetics
JP2017137323A (ja) 新規抗がん剤
CN1166623C (zh) 2-苯氧基苯胺类衍生物
CN114456150A (zh) Nr2b受体拮抗剂或其可药用的盐、制备方法及用途